David Price | CFO |
Nancy Lurker | President and CEO |
Andrew D'Silva | B. Riley FBR |
Yi Chen | H.C. Wainwright |
Good morning. My name is Skyler, and I will be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharmaceuticals' first quarter 2019 financial results conference call. There will be a question and answer session to follow at the completion of the prepared remarks. Please be advised that this call is being recorded at the company's request.